BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics

  Cedilla Therapeutics today formally announced the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein stability mechanisms to redirect the course of disease.

  June 28, 2018

   · 

  3 min read
• Business

  Walgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results

  Sales increased 14.0 percent to $34.3 billion

  June 28, 2018

   · 

  35 min read
• Policy

  Lipoprotein(a) Foundation Announces Two ICD-10 Diagnostic Codes for Elevated Lipoprotein(a) Approved by the CDC

  New ICD-10 Codes Could Accelerate Access to Simple Blood Test for Elevated Lipoprotein(a) and Help Prevent Cardiovascular Events in People Whose Only Risk Factor is Lipoprotein(a).

  June 28, 2018

   · 

  4 min read
• 

  Genetown

  Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100

  Arsanis, Inc. (NASDAQ:ASNS), today announced the discontinuation of its Phase 2 clinical trial of ASN100.

  June 28, 2018

   · 

  5 min read